Tourmaline Bio Inc saw a rather unpredictable run in, in terms of market performance. The company’s stock reached its highest point at $48.31 on 03/13/24, while the lowest price for the same duration was marked at $9.18 on 10/23/23.
52-week price history of TRML Stock
A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Tourmaline Bio Inc’s current trading price is -65.47% away from its 52-week high, while its distance from the 52-week low is 81.70%. The stock’s price range during this period has spanned from $9.18 to $48.31. In the Healthcare sector, the Tourmaline Bio Inc’s shares surpassed a trading volume of approximately 0.59 million for the day, which was noticeably higher compared to the average daily volume of 9.0.38 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Tourmaline Bio Inc (TRML) has experienced a quarterly decline of -46.79% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 427.84M and boasts a workforce of 52 employees.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 29.52, with a change in price of -0.91. Similarly, Tourmaline Bio Inc recorded 301,320 in trading volume during the last 100 days, posting a change of -5.17%.
Examining TRML’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for TRML stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
TRML Stock Stochastic Average
Today, Tourmaline Bio Inc’s raw stochastic average for the past 50 days stands at 1.19%, indicating a decline from the raw stochastic average of the last 20 days, which was 1.30%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 0.87% and 1.30% respectively.
TRML Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. The index has shown a price loss of -36.29% this year. Over the last six months, there has been a stronger performance of -44.40%. The price of TRML leaped by -58.31% during the last 30 days period. For the last 5-days stocks have slided -16.22%.
